{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T05:45:25Z","timestamp":1648705525177},"reference-count":23,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2014,7,4]],"date-time":"2014-07-04T00:00:00Z","timestamp":1404432000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"DOI":"10.1007\/s11655-014-1838-y","type":"journal-article","created":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T18:42:22Z","timestamp":1404412942000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expert consensus for postmarketing Chinese medicine intensive hospital safety monitoring"],"prefix":"10.1007","author":[{"given":"Xing","family":"Liao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-ming","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-bin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-quan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao-xiang","family":"Xian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze-huai","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong-qi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-dong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-sheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-jie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian-xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-peng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,4]]},"reference":[{"key":"1838_CR1","unstructured":"Law for administration of drugs of the People\u2019s Republic of China (Order of the President of the People\u2019s Republic of China No. 45). http:\/\/www.sda.gov.cn\/WS01\/CL0064\/23396.html"},{"key":"1838_CR2","first-page":"5","volume-title":"Design methodology and implementation of clinical re-assessment of postmarketing Chinese medicines","author":"YY Wang","year":"2012","unstructured":"Wang YY, Du XX, Lu AP. Design methodology and implementation of clinical re-assessment of postmarketing Chinese medicines, Beijing: People\u2019s Medical Publishing House; 2012:5."},{"key":"1838_CR3","first-page":"2683","volume":"37","author":"W Yang","year":"2012","unstructured":"Yang W, Xie YM, Wang YY. Study on clinical effectiveness of chinese medicines-interpretations of registry-based intensive hospital monitoring plan for parenterally administered Chinese medicines. Chin J Chin Mater Med (Chin) 2012;37:2683\u20132685.","journal-title":"Chin J Chin Mater Med (Chin)"},{"key":"1838_CR4","unstructured":"Postal questionnaire of the safety supervision department of the State Food and Drug Administration concerning notice concerning promoting intensive medicine monitoring in manufacturers and guidelines for intensive medicine monitoring in manufacturers (exposure draft). http:\/\/www.sda.gov.cn\/WS01\/CL0778\/79321.html"},{"key":"1838_CR5","unstructured":"Guidelines for Intensive Medicine Monitoring in Manufacturers (exposure draft). http:\/\/www.sda.gov.cn\/WS01\/CL0778\/79321.html"},{"key":"1838_CR6","first-page":"28","volume-title":"Textbook of pharmacoepidemiology","year":"2008","unstructured":"Strom BL, Kimmel SE, eds. Translator: Zeng FD, Shi LY, Zhan SY. Textbook of pharmacoepidemiology. New York: John Wiley & Sons (Asia) Pte Ltd; 2008:28."},{"key":"1838_CR7","volume-title":"Pharmacopoeia of the People\u2019s Republic of China: edition 2011","author":"National Pharmacopoeia Committee.","year":"2010","unstructured":"National Pharmacopoeia Committee. Pharmacopoeia of the People\u2019s Republic of China: edition 2011. Beijing: China Medical Sciences Press; 2010: Appendix 13."},{"key":"1838_CR8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/bmj.1.5643.531","volume":"1","author":"N Hurwitz","year":"1969","unstructured":"Hurwitz N, Wade OL. Intensive hospital monitoring of adverse reactions to drugs. Br Med J 1969;1:531.","journal-title":"Br Med J"},{"key":"1838_CR9","first-page":"126","volume-title":"Clinical Epidemiology","year":"2008","unstructured":"Wang JL, ed. Clinical Epidemiology. Beijing: People\u2019s Medical Publishing House; 2008:126."},{"key":"1838_CR10","unstructured":"Measures for administration of reporting and monitoring of adverse drug reaction (Order No. 81 of the Ministry of Health of the People\u2019s Republic of China). http:\/\/www.moh.gov.cn\/mohzcfgs\/pgz\/201105\/51770.shtml"},{"key":"1838_CR11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0895-4356(94)90164-3","volume":"47","author":"P Tubert-Bitter","year":"1994","unstructured":"Tubert-Bitter P, Begaud B, Moride Y, Abenhaim L. Sample size calculations for single groups postmarketing cohort studies. J Clin Epidemiol 1994:47:435\u2013439.","journal-title":"J Clin Epidemiol"},{"key":"1838_CR12","first-page":"87","volume":"40","author":"Y-T Wu","year":"2006","unstructured":"Wu Y-Te, Makuch RW. Detecting rare adverse events in postmarketing studies: sample size considerations. Drug Inf J 2006;40:87\u201396.","journal-title":"Drug Inf J"},{"key":"1838_CR13","first-page":"42","volume-title":"Guidelines for clinical applications of parenterally administered Chinese medicines","year":"2011","unstructured":"Ren DQ, Zhang BL, Weng WL, eds. Guidelines for clinical applications of parenterally administered Chinese medicines. Beijing: People\u2019s Medical Publishing House; 2011:42."},{"key":"1838_CR14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","volume":"117","author":"HA Sampson","year":"2006","unstructured":"Sampson HA, Mu\u00f1oz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006;117:391\u2013397.","journal-title":"J Allergy Clin Immunol"},{"key":"1838_CR15","first-page":"250","volume-title":"Practical Internal Medicine","year":"2009","unstructured":"Dai ZY, Chen HZ, Lin GW, eds. Practical Internal Medicine. Beijing: People\u2019s Medical Publishing House; 2009:250\u2013251, 1904\u2013190."},{"key":"1838_CR16","volume-title":"World Medical Association","author":"World Medical Association.","year":"2008","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. World Medical Association, 2008."},{"key":"1838_CR17","first-page":"107","volume":"8","author":"QY Pu","year":"2003","unstructured":"Pu QY, Xiong NN, Wu J. International ethical guidelines for biomedical research involving human subjects. Chin J Clin Pharmacol Ther (Chin) 2003;8:107.","journal-title":"Chin J Clin Pharmacol Ther (Chin)"},{"key":"1838_CR18","first-page":"2764","volume":"36","author":"YM Xie","year":"2011","unstructured":"Xie YM, Wang YP, Tian F, Wang Y. Basic requirements on post-marketing clinical re-evaluation of Chinese medicine and phase IV clinical trials. China J Chin Mater Med (Chin) 2011;36:2764\u20132767.","journal-title":"China J Chin Mater Med (Chin)"},{"key":"1838_CR19","first-page":"2824","volume":"37","author":"Y Xiao","year":"2012","unstructured":"Xiao Y, Zhao YB, Xie YM. Experimental study of suspicious component screening on Huachansu injection. China J Chin Mater Med (Chin) 2012;37:2824\u20132827.","journal-title":"China J Chin Mater Med (Chin)"},{"key":"1838_CR20","first-page":"2958","volume":"38","author":"W Yang","year":"2013","unstructured":"Yang W, Xie YM. How to read and understand Registries for Evaluating Patient Outcomes: A User\u2019s Guide (2nd Edition). China J Chin Mater Med (Chin) 2013;38:2958\u20132962.","journal-title":"China J Chin Mater Med (Chin)"},{"key":"1838_CR21","first-page":"2963","volume":"38","author":"YM Xie","year":"2013","unstructured":"Xie YM, Tian F. Interpretation of Guidelines on Good Pharmacovigilance Practices for European Union. China J Chin Mater Med (Chin) 2013;38:2963\u20132968.","journal-title":"China J Chin Mater Med (Chin)"},{"key":"1838_CR22","first-page":"2943","volume":"38","author":"W Zhang","year":"2013","unstructured":"Zhang W, Xie YM, Yu WY. Exploration of how to formulate guidelines on post-marketing traditional Chinese medicine surveillance. China J Chin Mater Med (Chin) 2013;38:2943\u20132948.","journal-title":"China J Chin Mater Med (Chin)"},{"key":"1838_CR23","first-page":"2692","volume":"37","author":"LX Wang","year":"2012","unstructured":"Wang LX, Xie YM, Wang ZF. Research on establishment of clinical safety intensive hospital monitoring net of traditional Chinese medicine injection. China J Chin Mater Med (Chin) 2012;37:2692\u20132694.","journal-title":"China J Chin Mater Med (Chin)"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-014-1838-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11655-014-1838-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-014-1838-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T19:00:46Z","timestamp":1559415646000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11655-014-1838-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,4]]},"references-count":23,"alternative-id":["1838"],"URL":"https:\/\/doi.org\/10.1007\/s11655-014-1838-y","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,4]]}}}